A Phase 3 Study of OV101 in Pediatric Individuals With Angelman Syndrome (AS)

Condition:   Primary Disease or Condition Being Studied: Angelman Syndrome (AS) Intervention:   Drug: Gaboxadol Sponsor:   Ovid Therapeutics Inc. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials